Rebecca E. Schweppe, Ph.D.
Affiliations: | 2000 | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Area:
Molecular Biology, GeneticsGoogle:
"Rebecca Schweppe"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Arthur Gutierrez-Hartmann | grad student | 2000 | University of Colorado, Denver | |
| (Purification and mass spectrometric identification of GABP as a nuclear mediator of growth factor-regulated prolactin gene expression.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rose MM, Nassar KW, Sharma V, et al. (2023) AKT-independent signaling in PIK3CA-mutant thyroid cancer mediates resistance to dual SRC and MEK1/2 inhibition. Medical Oncology (Northwood, London, England). 40: 299 |
| Bolf EL, Beadnell TC, Rose MM, et al. (2023) Dasatinib and Trametinib Promote Anti-Tumor Metabolic Activity. Cells. 12 |
| Hicks HM, Pozdeyev N, Sams SB, et al. (2023) Fibronectin contributes to a BRAF inhibitor-driven invasive phenotype in thyroid cancer through EGR1, which can be blocked by inhibition of ERK1/2. Molecular Cancer Research : McR |
| Rose MM, Espinoza VL, Hoff KJ, et al. (2023) BCL2L11 Induction Mediates Sensitivity to Src and MEK1/2 Inhibition in Thyroid Cancer. Cancers. 15 |
| Pozdeyev N, Rose MM, Bowles DW, et al. (2020) Molecular therapeutics for anaplastic thyroid cancer. Seminars in Cancer Biology |
| Landa I, Pozdeyev N, Knauf JA, et al. (2019) Genetics of Human Thyroid Cancer Cell Lines-Response. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 25: 6883-6884 |
| Landa-Lopez I, Pozdeyev N, Korch C, et al. (2019) Comprehensive genetic characterization of human thyroid cancer cell lines: a validated panel for preclinical studies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Schweppe RE, Pozdeyev N, Pike LA, et al. (2019) Establishment and characterization of four novel thyroid cancer cell lines and PDX models expressing the RET/PTC1 rearrangement, BRAFV600E, or RASQ61R as drivers. Molecular Cancer Research : McR |
| Kellett M, Kessler B, Mishall K, et al. (2019) SAT-574 Elucidating the Role of Nuclear Focal Adhesion Kinase (FAK) in Thyroid Cancer Journal of the Endocrine Society. 3 |
| Nassar KW, Hintzsche J, Bagby S, et al. (2019) Abstract B076: Uncoupling of the cell cycle pathway from the MAPK pathway in BRAF/MEK inhibitor resistant melanoma Molecular Cancer Therapeutics. 18 |